Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Harmony Biosciences Holdings, Inc.
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
August 26, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
August 21, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025
August 05, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025
June 11, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
June 05, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
June 04, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance
May 06, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025
April 29, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome
April 08, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
April 03, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands
March 24, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Participate in Upcoming Investor Conferences
March 04, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs
February 25, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia
February 19, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
February 18, 2025
From
Harmony Biosciences Holdings, Inc.
Via
Business Wire
Tickers
HRMY
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.